Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76,274 | 82 | 70.2% |
| Food and Beverage | $16,500 | 775 | 15.2% |
| Travel and Lodging | $14,719 | 30 | 13.5% |
| Consulting Fee | $1,095 | 2 | 1.0% |
| Gift | $59.40 | 1 | 0.1% |
| Education | $38.44 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $61,033 | 274 | $0 (2024) |
| Lilly USA, LLC | $31,112 | 173 | $0 (2024) |
| MannKind Corporation | $4,925 | 48 | $0 (2023) |
| Abbott Laboratories | $2,678 | 24 | $0 (2024) |
| Zealand Pharma US, Inc. | $2,338 | 19 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $663.27 | 35 | $0 (2022) |
| Dexcom, Inc. | $655.82 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $565.37 | 29 | $0 (2024) |
| Amgen Inc. | $458.21 | 31 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $386.41 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,047 | 85 | Lilly USA, LLC ($15,706) |
| 2023 | $33,566 | 255 | Lilly USA, LLC ($14,535) |
| 2022 | $30,317 | 261 | Novo Nordisk Inc ($26,275) |
| 2021 | $23,757 | 292 | Novo Nordisk Inc ($19,689) |
All Payment Transactions
893 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardio-renal | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Diabetes Care | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.68 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $95.69 | General |
| Category: Endocrinology | ||||||
| 08/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 545 | 938 | $250,394 | $75,680 |
| 2022 | 7 | 537 | 936 | $276,199 | $88,362 |
| 2021 | 7 | 406 | 591 | $157,639 | $56,316 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 188 | 443 | $154,018 | $45,566 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 168 | $42,322 | $13,493 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 44 | 44 | $18,656 | $5,744 | 30.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 101 | 192 | $12,819 | $4,062 | 31.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 30 | 30 | $8,447 | $3,059 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,004 | $2,295 | 28.7% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 12 | 19 | $6,043 | $1,406 | 23.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 17 | $85.00 | $54.57 | 64.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 203 | 531 | $184,587 | $58,423 | 31.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 106 | 106 | $44,832 | $14,328 | 32.0% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 61 | 66 | $19,181 | $7,137 | 37.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 84 | 116 | $7,859 | $2,616 | 33.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 43 | 74 | $8,246 | $2,438 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 28 | $6,791 | $1,861 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,704 | $1,558 | 33.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 110 | 237 | $78,547 | $28,054 | 35.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 78 | 78 | $31,468 | $11,044 | 35.1% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 48 | 49 | $14,451 | $5,856 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 53 | $12,572 | $4,536 | 36.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 41 | 80 | $9,438 | $3,185 | 33.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $6,415 | $1,908 | 29.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 67 | 73 | $4,748 | $1,734 | 36.5% |
About Jeremy Schmidt, APNP
Jeremy Schmidt, APNP is a Family healthcare provider based in New Braunfels, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1184892622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeremy Schmidt, APNP has received a total of $108,686 in payments from pharmaceutical and medical device companies, with $21,047 received in 2024. These payments were reported across 893 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($76,274).
As a Medicare-enrolled provider, Schmidt has provided services to 1,488 Medicare beneficiaries, totaling 2,465 services with total Medicare billing of $220,358. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family
- Location New Braunfels, TX
- Active Since 02/19/2008
- Last Updated 10/16/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1184892622
Products in Payments
- Ozempic (Drug) $31,369
- MOUNJARO (Drug) $20,652
- Rybelsus (Drug) $18,305
- RYBELSUS (Drug) $6,231
- V-GO (Device) $4,332
- FREESTYLE LIBRE 3 (Device) $2,534
- ZEGALOGUE (Drug) $2,151
- JARDIANCE (Drug) $718.29
- FARXIGA (Drug) $663.27
- Dexcom G6 Transmitter (Medical Supply) $593.93
- AFREZZA (Drug) $593.28
- Kerendia (Drug) $386.41
- Korlym (Drug) $355.34
- Vascepa (Drug) $282.14
- TRULICITY (Drug) $260.20
- Repatha (Biological) $246.32
- HUMULIN (Drug) $225.67
- BAQSIMI (Drug) $203.80
- V-GO DISPOSABLE INSULIN DELIVERY (Device) $186.53
- UNITHROID (Drug) $175.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in New Braunfels
Traci Thompson
Family — Payments: $8,630
Jennifer Upton, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $6,838
Chyrissa Staley, F.n.p, F.N.P
Family — Payments: $6,180
Erica Ormeno
Family — Payments: $5,031
Danielle Harpe, Fnp, FNP
Family — Payments: $4,670
Mrs. Kimberly Ha, Fnp, FNP
Family — Payments: $4,479